These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9790165)

  • 1. Quality of life and atypical antipsychotics.
    Rudnick A
    J Clin Psychopharmacol; 1998 Oct; 18(5):424-5. PubMed ID: 9790165
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
    J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
    Kasper S; Küfferle B
    J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
    de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
    J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
    Tran PV; Hamilton SH; Kuntz AJ; Potvin JH; Andersen SW; Beasley C; Tollefson GD
    J Clin Psychopharmacol; 1997 Oct; 17(5):407-18. PubMed ID: 9315992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics and cardiovascular risk in schizophrenic patients.
    Bouchard RH; Demers MF; Simoneau I; Alméras N; Villeneuve J; Mottard JP; Cadrin C; Lemieux I; Després JP
    J Clin Psychopharmacol; 2001 Feb; 21(1):110-1. PubMed ID: 11199934
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.
    Aubry JM; Simon AE; Bertschy G
    J Clin Psychiatry; 2000 Sep; 61(9):649-55. PubMed ID: 11030485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
    Casey DE; Daniel DG; Wassef AA; Tracy KA; Wozniak P; Sommerville KW
    Neuropsychopharmacology; 2003 Jan; 28(1):182-92. PubMed ID: 12496955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothermia induced by risperidone and olanzapine in a patient with Prader-Willi syndrome.
    Phan TG; Yu RY; Hersch MI
    Med J Aust; 1998 Aug; 169(4):230-1. PubMed ID: 9734590
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia.
    Kores Plesnicar B; Zalar B; Tomori M; Krajnc I
    Wien Klin Wochenschr; 2003 Jan; 115(1-2):58-62. PubMed ID: 12658913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on article by Tran and colleagues, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
    Schooler NR
    J Clin Psychopharmacol; 1998 Apr; 18(2):174-6. PubMed ID: 9555605
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
    Gheuens J; Grebb JA
    J Clin Psychopharmacol; 1998 Apr; 18(2):176-9. PubMed ID: 9555606
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients.
    Dinakar HS; Sobel RN; Bopp JH; Daniels A; Mauro S
    Psychiatr Serv; 2002 Jun; 53(6):755-7. PubMed ID: 12045315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the atypical antipsychotic drugs antidepressants?
    Parker G; Malhi G
    J Clin Psychopharmacol; 2002 Feb; 22(1):94-5. PubMed ID: 11799351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.